Sun Pharmaceutical Industries has introduced its globally successful biologic therapy Ilumya (Tildrakizumab) in India, marking a major expansion of its specialty medicines portfolio in its home market. The launch brings to Indian patients a treatment that has already built blockbuster status across 35 countries, including the US. A Significant Step in Sun Pharma’s Specialty PushIlumya … Continue reading Sun Pharma Launches Blockbuster Psoriasis Drug Ilumya in India